YU35600A - Uretani izvedeni od azacikloalkana, njihovi tio- i ditio- analozi, njihovo dobijanje i njihova primena kao inhibitora 2,3-epoksiskvalen-lanosterol-ciklaze - Google Patents
Uretani izvedeni od azacikloalkana, njihovi tio- i ditio- analozi, njihovo dobijanje i njihova primena kao inhibitora 2,3-epoksiskvalen-lanosterol-ciklazeInfo
- Publication number
- YU35600A YU35600A YU35600A YU35600A YU35600A YU 35600 A YU35600 A YU 35600A YU 35600 A YU35600 A YU 35600A YU 35600 A YU35600 A YU 35600A YU 35600 A YU35600 A YU 35600A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- group
- represent
- alkyl
- atom
- oxygen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fodder In General (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Pronalazak se odnosi na uretane izvedene od azacikloalkana, kao i na njihove tio- i ditio-analoge, opste formule (I), u kojoj oznacavaju, m brojeve 0 ili 1, n brojeve 1 ili 2, A, prostu vezu, sa pravim ili razgranatim nizom C1-8-alkilen-grupu, C2-8-alkenilen- ili C2-8-alkinilen-grupu, pri cemu nezasicena grupa nije direktno vezana za ostatak Y, a X i Y atom kiseonika ili sumpora, R1 i R2, sa pravim ili razgranatim nizom C1-6-alkil-grupu, C1-4-alkenil grupu ili C-1-4alkinil-grupu, pri cemu je visestruka veza izolovana od veze azot-ugljenik, ili R1 i R2 zajedno sa atomom azota, oznacavaju 5- do 7-clani, zasicen heterociklican prsten, u kome metilen-grupa, izolovana od atoma azota, moze da bude zamenjena sa atomom kiseonika ili sumpora ili sa -NH- ili -N(alkil)-grupom, R3 do R6, koji mogu biti isti ili razliciti, atome vodonika ili alkil-grupe, R7 oznacava C3-7-cikloalkil-grupu, u datom slucaju, sa jednim ili dva atoma halogena, sa alkil-, alkoksi-, trifluorometil- ili cijano-grupom supstituisanu fenil- ili naftil-grupu, ili takodje i atom vodonika, ukoliko A ne predstavlja prostu vezu, E, atom kiseonika ili sumpora, metilen-, karbonil- ili sulfinil-grupu, a R8, atom vodonika, ili E, grupu-C(R9R10)-, pri cemu R9 oznacava atom vodonika, a R10, zajedno sa susednom grupom R8, predstavlja vezu ugljenik-ugljenik, na njihove enantiomere, dijastereomere i njihove soli, narocito njihove fizioloski podnosljive adicione soli sa kiselinom, koje imaju dragocena svojstva, narocito inhibitorsko dejstvo na biosintezu holesterola, na lekove koji sadrze ova jedinjenja, na njihovu primenu i na postupke za njihovo pripremanje.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19754796A DE19754796A1 (de) | 1997-12-10 | 1997-12-10 | Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
YU35600A true YU35600A (sh) | 2002-09-19 |
Family
ID=7851381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU35600A YU35600A (sh) | 1997-12-10 | 1998-12-08 | Uretani izvedeni od azacikloalkana, njihovi tio- i ditio- analozi, njihovo dobijanje i njihova primena kao inhibitora 2,3-epoksiskvalen-lanosterol-ciklaze |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1060162B1 (sh) |
JP (1) | JP3418688B2 (sh) |
KR (1) | KR20010032977A (sh) |
CN (1) | CN1281434A (sh) |
AR (1) | AR017827A1 (sh) |
AT (1) | ATE234816T1 (sh) |
AU (1) | AU1759499A (sh) |
BG (1) | BG104500A (sh) |
BR (1) | BR9813495A (sh) |
CA (1) | CA2309388A1 (sh) |
CO (1) | CO5370694A1 (sh) |
DE (2) | DE19754796A1 (sh) |
DK (1) | DK1060162T3 (sh) |
EA (1) | EA200000631A1 (sh) |
EE (1) | EE200000342A (sh) |
ES (1) | ES2190130T3 (sh) |
HR (1) | HRP20000377A2 (sh) |
HU (1) | HUP0100335A3 (sh) |
IL (1) | IL135738A0 (sh) |
NO (1) | NO20002967L (sh) |
PL (1) | PL341060A1 (sh) |
PT (1) | PT1060162E (sh) |
SK (1) | SK8612000A3 (sh) |
TR (1) | TR200001635T2 (sh) |
WO (1) | WO1999029669A1 (sh) |
YU (1) | YU35600A (sh) |
ZA (1) | ZA9811262B (sh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1351936A1 (en) * | 2001-01-15 | 2003-10-15 | Glaxo Group Limited | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
US20040147557A1 (en) * | 2001-01-15 | 2004-07-29 | Anne Bouillot | Aryl piperidine derivatives as inducers of ldl-receptor expression |
US20040072865A1 (en) * | 2001-01-15 | 2004-04-15 | Bouillot Anne Marie Jeanne | Aryl piperidine derivatives as inducers of ldl-receptor expression |
DE10132686A1 (de) * | 2001-07-05 | 2003-01-16 | Boehringer Ingelheim Pharma | Heteroarylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
JP4664634B2 (ja) * | 2003-09-05 | 2011-04-06 | 富山化学工業株式会社 | 新規なベンズアミジン誘導体またはその塩 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04312572A (ja) * | 1991-04-12 | 1992-11-04 | Takeda Chem Ind Ltd | 環状アミン化合物 |
DE4407136A1 (de) * | 1994-03-04 | 1995-09-07 | Thomae Gmbh Dr K | Aroyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung |
DE4407138A1 (de) * | 1994-03-04 | 1995-09-07 | Thomae Gmbh Dr K | Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung |
-
1997
- 1997-12-10 DE DE19754796A patent/DE19754796A1/de not_active Withdrawn
-
1998
- 1998-12-08 JP JP2000524266A patent/JP3418688B2/ja not_active Expired - Fee Related
- 1998-12-08 PL PL98341060A patent/PL341060A1/xx unknown
- 1998-12-08 EE EEP200000342A patent/EE200000342A/xx unknown
- 1998-12-08 HU HU0100335A patent/HUP0100335A3/hu unknown
- 1998-12-08 IL IL13573898A patent/IL135738A0/xx unknown
- 1998-12-08 BR BR9813495-7A patent/BR9813495A/pt not_active IP Right Cessation
- 1998-12-08 SK SK861-2000A patent/SK8612000A3/sk unknown
- 1998-12-08 DE DE59807591T patent/DE59807591D1/de not_active Expired - Fee Related
- 1998-12-08 CN CN98811959A patent/CN1281434A/zh active Pending
- 1998-12-08 PT PT98962423T patent/PT1060162E/pt unknown
- 1998-12-08 YU YU35600A patent/YU35600A/sh unknown
- 1998-12-08 WO PCT/EP1998/007965 patent/WO1999029669A1/de not_active Application Discontinuation
- 1998-12-08 AU AU17594/99A patent/AU1759499A/en not_active Abandoned
- 1998-12-08 TR TR2000/01635T patent/TR200001635T2/xx unknown
- 1998-12-08 CA CA002309388A patent/CA2309388A1/en not_active Abandoned
- 1998-12-08 KR KR1020007006326A patent/KR20010032977A/ko not_active Application Discontinuation
- 1998-12-08 ES ES98962423T patent/ES2190130T3/es not_active Expired - Lifetime
- 1998-12-08 EP EP98962423A patent/EP1060162B1/de not_active Expired - Lifetime
- 1998-12-08 EA EA200000631A patent/EA200000631A1/ru unknown
- 1998-12-08 AT AT98962423T patent/ATE234816T1/de not_active IP Right Cessation
- 1998-12-08 DK DK98962423T patent/DK1060162T3/da active
- 1998-12-09 ZA ZA9811262A patent/ZA9811262B/xx unknown
- 1998-12-09 CO CO98073126A patent/CO5370694A1/es not_active Application Discontinuation
- 1998-12-09 AR ARP980106228A patent/AR017827A1/es not_active Withdrawn
-
2000
- 2000-06-02 BG BG104500A patent/BG104500A/bg active Pending
- 2000-06-07 HR HR20000377A patent/HRP20000377A2/hr not_active Application Discontinuation
- 2000-06-09 NO NO20002967A patent/NO20002967L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999029669A1 (de) | 1999-06-17 |
EA200000631A1 (ru) | 2000-12-25 |
HUP0100335A3 (en) | 2001-11-28 |
SK8612000A3 (en) | 2000-11-07 |
EE200000342A (et) | 2001-08-15 |
CO5370694A1 (es) | 2004-02-27 |
BG104500A (bg) | 2001-03-30 |
JP2001525397A (ja) | 2001-12-11 |
AU1759499A (en) | 1999-06-28 |
CN1281434A (zh) | 2001-01-24 |
AR017827A1 (es) | 2001-10-24 |
IL135738A0 (en) | 2001-05-20 |
NO20002967L (no) | 2000-08-09 |
KR20010032977A (ko) | 2001-04-25 |
CA2309388A1 (en) | 1999-06-17 |
BR9813495A (pt) | 2000-10-10 |
ZA9811262B (en) | 2000-06-09 |
EP1060162B1 (de) | 2003-03-19 |
ATE234816T1 (de) | 2003-04-15 |
ES2190130T3 (es) | 2003-07-16 |
JP3418688B2 (ja) | 2003-06-23 |
HRP20000377A2 (en) | 2000-12-31 |
PL341060A1 (en) | 2001-03-26 |
TR200001635T2 (tr) | 2000-11-21 |
DK1060162T3 (da) | 2003-07-14 |
HUP0100335A2 (hu) | 2001-07-30 |
DE59807591D1 (de) | 2003-04-24 |
PT1060162E (pt) | 2003-08-29 |
NO20002967D0 (no) | 2000-06-09 |
DE19754796A1 (de) | 1999-06-17 |
EP1060162A1 (de) | 2000-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1477114A (en) | 1,4-dihydropyridinecarboxylic acid aralkyl esters processes for their preparation and their use as medicaments | |
IL135180A0 (en) | Sulfonyl derivatives | |
ATE236882T1 (de) | Bicyklische fibrinogen antagoniste | |
WO1999033858A3 (en) | Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use | |
WO1995032190A3 (en) | Pharmaceutical diketopiperazine compounds | |
RO115159B1 (ro) | Derivaţi de piperazină şi compoziţii farmaceutice care îi conţin | |
DE3675087D1 (de) | Pyridoncarbonsauere-derivate und verfahren zu ihrer herstellung. | |
FR2672598B1 (sh) | ||
YU35600A (sh) | Uretani izvedeni od azacikloalkana, njihovi tio- i ditio- analozi, njihovo dobijanje i njihova primena kao inhibitora 2,3-epoksiskvalen-lanosterol-ciklaze | |
ATE285410T1 (de) | Naphthyridinderivate oder salze davon | |
FR2669927B1 (fr) | Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
YU5199A (sh) | Farmaceutski proizvodi za lečenje i sprečavanje bolesti nastalih od oštećenja vaskularnih endotelialnih ćelija | |
BG105123A (en) | Tetrahydroquinaline derivatives as glycine antagonists | |
HRP20050617A2 (en) | Imidazol derivatives having affinity for alpha 2 receptors activity | |
ES8703409A1 (es) | Un metodo para preparar un derivado de urea sustituido con aminoalquilo | |
ES2179548T3 (es) | Nuevos derivados de la acronicina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
EA200101204A1 (ru) | Новые бициклические соединения аминопиразинона, способ их получения и содержащие их фармацевтические композиции | |
EA200000527A2 (ru) | Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
AU4947996A (en) | Arginine analogs acting as inhibitors of the NO synthase | |
DE3671016D1 (de) | Thiazolidinderivate und verfahren zu ihrer herstellung. | |
SE8804436L (sv) | Trombolytiska och liknande sammansaettningar | |
TW326439B (en) | Octahydornaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use | |
RU96120092A (ru) | Новые производные пиперазина и способы их получения и содержащие их композиции | |
TH6029A (th) | อนุพันธ์ของควิโนลิเนียม และไอโซควิโนลิเนียมที่ควบแน่น | |
TH6029EX (th) | อนุพันธ์ของควิโนลิเนียม และไอโซควิโนลิเนียมที่ควบแน่น |